The reconstituted National Medical Device Promotion Council (NMDPC) under the Department of Pharmaceuticals, in its first meeting held at Dr Ambedkar International Centre in New Delhi, was updated on the steps taken up by the Central Drugs Standards and Control Organisation (CDSCO) and the State Licensing Authorities (SLAs) for the smooth transition to licensing of Class A and B Medical Devices w.e.f October 1, 2022.

The council under the chair of the Secretary, Department of Pharmaceuticals has members from stakeholder departments/organisations, functions of which have a bearing on the growth of the sector and has representation from several medical device industry associations, representing the sector in India. The NMDPC deliberated on the important issues of the medtech industry. 

At the outset, the Department of Pharmaceuticals presented the latest status of the various initiatives taken by the Department for the sector to the Council such as 100 per cent FDI in the medtech sector on the automatic route, PLI scheme for medical devices, medical devices parks in four states, assistance for common infrastructure facility of superconducting magnetic coil testing facility, etc. The department is also engaging the medical devices industries for arriving at a consensus on the industry issues by forming standing forums and by organising regulatory round tables. 

Department of Health and Family Welfare updated the preparedness for transition to licensing of Class-A and Class-B medical devices, w.e.f October 1, 2022, under Medical Devices Rules 2017. 

Another important issue deliberated was to reduce the regulatory burden of labelling requirements of Medical Devices. The council, after deliberating the issues with the industry associations, suggested to the Health Regulator to move forward to harmonise the provisions of labelling of Medical Devices under the Legal Metrology (Packaged Commodity) Rules, 2011 into Medical Device Rules, 2017, for the licensed medical devices.